I think the answer to the board questions lies with the quick movement of RAW's major shareholder. I think he must have liked the deal.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025